Publicaciones en colaboración con investigadores/as de Erasmus University Medical Center (18)

2023

  1. Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))

    Nature communications

  2. Genetic Associations between Modifiable Risk Factors and Alzheimer Disease

    JAMA Network Open, Vol. 6, Núm. 5

  3. Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 36

2022

  1. Association of Rare APOE Missense Variants V236E and R251G with Risk of Alzheimer Disease

    JAMA Neurology, Vol. 79, Núm. 7, pp. 652-663

  2. New insights into the genetic etiology of Alzheimer's disease and related dementias

    Nature genetics, Vol. 54, Núm. 4, pp. 412-436

  3. Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery

    BJS Open, Vol. 6, Núm. 1

2021

  1. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Nature communications, Vol. 12, Núm. 1, pp. 3417

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Lipidomic profiling identifies signatures of metabolic risk

    EBioMedicine, Vol. 51

  2. Safeguarding children's right to health in hospital during COVID-19

    The Lancet Child and Adolescent Health

2019

  1. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

    Database, Vol. 2019, pp. 1-67

2017

  1. Bayesian joint modeling of bivariate longitudinal and competing risks data: An application to study patient-ventilator asynchronies in critical care patients

    Biometrical Journal, Vol. 59, Núm. 6, pp. 1184-1203

2016

  1. Economic evaluation of the breast cancer screening programme in the Basque Country: Retrospective cost-effectiveness and budget impact analysis

    BMC Cancer, Vol. 16, Núm. 1

2015

  1. ATPase-Dependent Control of the Mms21 SUMO Ligase during DNA Repair

    PLoS Biology, Vol. 13, Núm. 3

  2. Evaluation of health benefits and harms of the breast cancer screening programme in the Basque Country using discrete event simulation

    BMC Cancer, Vol. 15, Núm. 1

  3. The CHEMDNER corpus of chemicals and drugs and its annotation principles

    Journal of Cheminformatics, Vol. 7

2013

  1. Brush border myosin Ia inactivation in gastric but not endometrial tumors

    International Journal of Cancer, Vol. 132, Núm. 8, pp. 1790-1799

2006

  1. Phase III study of PSC-833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95): A trial of the Eastern Cooperative Oncology Group

    Cancer, Vol. 106, Núm. 4, pp. 830-838